Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-07-008784

Options or other derivatives

  • Chief Medical Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Harris Peter Chief Medical Officer 2007-01-25 Grant or award · Option to Purchase Common Stock +75,000 75,000 D: show line 1 in the form
Loading xslF345X02/rrd145073.xml…